Bernadette Connaughton's Net Worth
$5.19 Million
Who is Bernadette Connaughton?
Bernadette Connaughton has an estimated net worth of $5.19 Million. This is based on reported shares across multiple companies, which include Syneos Health, Inc., Editas Medicine, Inc., and HALOZYME THERAPEUTICS, INC..
SEC CIK
Bernadette Connaughton's CIK is 0001662521
Past Insider Trading and Trends
2023 was Bernadette Connaughton's most active year for acquiring shares with 4 total transactions. Bernadette Connaughton's most active month to acquire stocks was the month of April. 2023 was Bernadette Connaughton's most active year for disposing of shares, totalling 2 transactions. Bernadette Connaughton's most active month to dispose stocks was the month of August. 2020 saw Bernadette Connaughton paying a total of $174,991.29 for 11,632 shares, this is the most they've acquired in one year. In 2023 Bernadette Connaughton cashed out on 14,778 shares for a total of $426,345.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Syneos Health, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -14.78K |
$43.00 | -$426,345.00 |
0
|
Sep 28
| |||
Form 4
| +49.05% | 4.86K |
—
|
—
| 14.78K |
May 25
| |||
Form 4
| +40.12% | 2.84K |
—
|
—
| 9.91K |
May 25
| |||
Form 4
| +50.17% | 2.36K |
—
|
—
| 7.08K |
May 12
| |||
Form 4
| +146.83% | 2.8K |
$62.43 | $174,991.29 | 4.71K |
May 27
| |||
Form 4
|
∞
| 1.91K |
$49.48 | $94,457.32 | 1.91K |
Nov 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Editas Medicine, Inc. (EDIT) Snapshot price: $3.57
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HALOZYME THERAPEUTICS, INC. (HALO) Snapshot price: $59.21
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +16.14% | 6.5K |
—
|
—
| 46.79K |
Apr 25
| |||
Form 4
| +25.03% | 8.06K |
—
|
—
| 40.29K |
May 5
| |||
Form 4
| -15.69% | -6.00K |
—
|
—
| 32.22K |
Nov 16
| |||
Form 4
| +19.39% | 6.21K |
—
|
—
| 38.22K |
May 5
| |||
Form 4
| +19.53% | 5.23K |
—
|
—
| 32.01K |
May 5
| |||
Form 4
| +49.18% | 8.83K |
—
|
—
| 26.78K |
Apr 30
| |||
Form 4
| +210.57% | 12.17K |
—
|
—
| 17.95K |
May 2
| |||
Form 4
|
∞
| 5.78K |
—
|
—
| 5.78K |
Sep 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||